PDE4D isoforms are also down-regulated in androgen-insensitive prostate cancer cell lines, with PDE4D7 being of particular importance in regulating prostate cancer proliferation and suggested as a novel tumour biomarker [78]. Here, PDE4D is linked to prostate carcinoma.